AbbVie

Successor To Humira? AbbVie And Galapagos Work On It

Successor To Humira? AbbVie And Galapagos Work On It

Seeking Alpha

AbbVie announces preliminary results in Phase 1 study of ABT-199

AbbVie announces preliminary results in Phase 1 study of ABT-199

Yahoo/Fly on the Wall

AbbVie says it could beat Gilead to huge market for hep C drugs

AbbVie says it could beat Gilead to huge market for hep C drugs

Fierce Pharma

Is Concentration Better Than Diversification in Pharma?

Is Concentration Better Than Diversification in Pharma?

Motley Fool

New Data Improves Sales Outlook For Celgene's Apremilast

New Data Improves Sales Outlook For Celgene's Apremilast

TheStreet.com

Abbott Doubled Niaspan U.S. Sales Before Trials Cut Use

Abbott Doubled Niaspan U.S. Sales Before Trials Cut Use

Bloomberg

Is This GlaxoSmithKline's Next Big Blockbuster?

Is This GlaxoSmithKline's Next Big Blockbuster?

Motley Fool

AbbVie Ups Ante on JAK Inhibitor

AbbVie Ups Ante on JAK Inhibitor

Motley Fool

The Race For Oral HCV?

The Race For Oral HCV?

Seeking Alpha

AbbVie Price Boost of Drug Slammed in Studies Criticized

AbbVie Price Boost of Drug Slammed in Studies Criticized

Bloomberg